Jane Street’s PDS Biotechnology PDSB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$56.5K Buy
+75,200
New +$42.7K ﹤0.01% 10900
2023
Q3
– Sell
-23,800
Closed -$120K – 9184
2023
Q2
$120K Buy
+23,800
New +$156K ﹤0.01% 7928

Other funds holding PDSB

Jane Street's PDSB Position: Q3 2026 in Review

Jane Street increased its PDS Biotechnology (PDSB) stake by 83% in Q3 2026, buying an estimated $131K and bringing the position to 510,812 shares worth $383K. The position accounts for ﹤0.01% of the portfolio, ranked #8618.

Jane Street first reported a position in PDSB in Q2 2018 and has held it in 16 quarters since. The position peaked at $762K in Q1 2023. 60 funds tracked by Wall St. Rank hold PDSB as of Q3 2026.

  • Jane Street held 510,812 shares of PDS Biotechnology worth $383K as of Q3 2026.
  • Jane Street bought 231,148 PDS Biotechnology shares in Q3 2026, an estimated $131K.
  • PDS Biotechnology made up ﹤0.01% of Jane Street's portfolio in Q3 2026, its #8618 holding.
  • Jane Street first reported a position in PDS Biotechnology in Q2 2018 and has held it in 16 quarters since.
  • Jane Street's PDS Biotechnology position peaked at $762K in Q1 2023.
  • 60 funds tracked by Wall St. Rank held PDS Biotechnology as of Q3 2026.

Based on Jane Street's 13F filing for Q3 2026, filed 12 Nov 2026.